EFFECT OF EICOSAPENTAENOIC ACID ON RESTENOSIS RATE, CLINICAL COURSE AND BLOOD-LIPIDS IN PATIENTS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

被引：63
作者：
NYE, ER [1 ]
ABLETT, MB [1 ]
ROBERTSON, MC [1 ]
ILSLEY, CDJ [1 ]
SUTHERLAND, WHF [1 ]
机构：
[1] HAREFIELD HOSP,HAREFIELD,MIDDX,ENGLAND
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1990年 / 20卷 / 04期
关键词：
angioplasty; atherosclerosis; Eicosapentaenoic acid;
D O I：
10.1111/j.1445-5994.1990.tb01311.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Abstract In order to study the effects of eicosapentaenoic acid (Maxepa®), Maxepa® placebo and aspirin/dipyridamole combination on the clinical course and restenosis rate of atherosclerotic lesions after percutaneous transluminal coronary angioplasty 79 men and 29 women were randomly divided into three treatment groups and restudied angiographically within one year of the procedure. Angina recurred less in the Maxepa® group than in the other groups, although not statistically so. Restenosis rate was significantly reduced in the Maxepa® group (11%) compared to the placebo group (30%) but, while less, was not significantly lower than in the aspirin/dipyridamole group (17%). Maxepa® treatment appears to reduce restenosis rate of coronary artery lesions after percutaneous transluminal coronary angioplasty and may be an acceptable and equally effective alternative therapy to aspirin/dipyridamole. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码：549 / 552
页数：4
相关论文
共 15 条
  • [1] CHANGES IN GRAFTS AND CORONARY-ARTERIES AFTER SAPHENOUS-VEIN AORTOCORONARY BYPASS-SURGERY - RESULTS AT REPEAT ANGIOGRAPHY
    BOURASSA, MG
    CAMPEAU, L
    LESPERANCE, J
    GRONDIN, CM
    [J]. CIRCULATION, 1982, 65 (07) : 90 - 97
  • [2] IMPROVED GRAFT PATENCY WITH ANTI-PLATELET DRUGS IN PATIENTS TREATED FOR ONE YEAR FOLLOWING CORONARY-BYPASS SURGERY
    BROWN, BG
    CUKINGNAN, RA
    GOEDE, L
    WONG, M
    FEE, H
    ROTH, J
    WITTIG, J
    CAREY, J
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02) : 494 - 494
  • [3] CAMPAEU L, 1979, CIRCULATION S1, V80, P1
  • [4] A PLATELET-INHIBITOR-DRUG TRIAL IN CORONARY-ARTERY BYPASS OPERATIONS - BENEFIT OF PERIOPERATIVE DIPYRIDAMOLE AND ASPIRIN THERAPY ON EARLY POSTOPERATIVE VEIN-GRAFT PATENCY
    CHESEBRO, JH
    CLEMENTS, IP
    FUSTER, V
    ELVEBACK, LR
    SMITH, HC
    BARDSLEY, WT
    FRYE, RL
    HOLMES, DR
    VLIETSTRA, RE
    PLUTH, JR
    WALLACE, RB
    PUGA, FJ
    ORSZULAK, TA
    PIEHLER, JM
    SCHAFF, HV
    DANIELSON, GK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (02) : 73 - 78
  • [5] REDUCTION IN THE RATE OF EARLY RESTENOSIS AFTER CORONARY ANGIOPLASTY BY A DIET SUPPLEMENTED WITH N-3 FATTY-ACIDS
    DEHMER, GJ
    POPMA, JJ
    VANDENBERG, EK
    EICHHORN, EJ
    PREWITT, JB
    CAMPBELL, WB
    JENNINGS, L
    WILLERSON, JT
    SCHMITZ, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (12) : 733 - 740
  • [6] DEHMER GJ, 1988, NEW ENGL J MED, V12, P319
  • [7] CORONARY-BYPASS GRAFT FATE - ANGIOGRAPHIC GRADING OF 1400 CONSECUTIVE GRAFTS EARLY AFTER OPERATION AND OF 1132 AFTER ONE YEAR
    FITZGIBBON, GM
    BURTON, JR
    LEACH, AJ
    [J]. CIRCULATION, 1978, 57 (06) : 1070 - 1074
  • [8] TRANS-LUMINAL DILATATION OF CORONARY-ARTERY STENOSIS
    GRUNTZIG, A
    [J]. LANCET, 1978, 1 (8058) : 263 - 263
  • [9] THE COMPARATIVE REDUCTIONS OF THE PLASMA-LIPIDS AND LIPOPROTEINS BY DIETARY POLY-UNSATURATED FATS - SALMON OIL VERSUS VEGETABLE-OILS
    HARRIS, WS
    CONNOR, WE
    MCMURRY, MP
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (02): : 179 - 184
  • [10] PERSANTINE-ASPIRIN REINFARCTION STUDY .2. SECONDARY CORONARY PREVENTION WITH PERSANTINE AND ASPIRIN
    KLIMT, CR
    KNATTERUD, GL
    STAMLER, J
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : 251 - 269
12